Navigation Links
Utilizing GPS-like Measurement Precision To More Accurately Determine Overall Performance
Date:8/12/2009

mprove workforce optimization, employee engagement, patient outcomes, productivity, and the net operating margin. The core purpose of HPS is to improve the health of healthcare, one organization at a time.

For more information or to receive a copy of the referenced white paper, please contact:

Mark Felts
Healthcare Performance Solutions
972.429.3885
mfelts (at) healthcareps.com
www.healthcareps.com

This press release was distributed through eMediawire by Human Resources Marketer (HR Marketer: www.HRmarketer.com) on behalf of the company listed above.

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2738804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
2. NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise
3. IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology
4. Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkins Lymphoma
5. Collexis Healthcare to Expand Capabilities for Asklepios Group Utilizing Microsoft Solutions
6. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
7. GPS-like technology helps pinpoint best methods for moving injured players
8. Brain Imaging (MRI/PET) and Measurements of Proteins in Spinal Fluid May Improve Alzheimers Prediction and Diagnosis
9. Measurements fail to identify TB patients who could benefit from shorter treatment course
10. Phreesia Works With Osteoporosis Experts to Expand its Measurement Guided Care Program
11. GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...’s attorneys are offering a free XOLAIR case... experienced heart attack, stroke or other serious... St. Louis, MO (Vocus) November 22, ...fering free XOLAIR case review for serious health...torneys of the Onder Law Firm include experienced ...
(Date:11/22/2009)...nt, diverse and constant, but inflammation is unde..., San Diego School of Medicine now shows that the ... a pathway that prevents excessive inflammation af... us," said Richard L. Gallo, MD, PhD, professor of... of Dermatology and the Dermatology section of the...
(Date:11/22/2009)...ntrol, expert says , , SUNDAY, Nov. 22 (... be faced with a seemingly endless buffet of food ...at too much, others deny themselves any holiday tr...overindulgence and deprivation, according to Julie... Brigham and Women,s Hospital in Boston. She offer...
(Date:11/22/2009)...post You Tube video demonstrating the Really Cool ... Landover, MD (PRWEB) November 22, 2009 --...at a really rugged waterproof keyboard can withsta...s Washable Competitors Keyboard HD” video on..., Really Cool Keyboard from Man & Machine, In...
(Date:11/21/2009)...USNewswire/ -- DNC Chairman Tim Kaine issued the f... full debate of health insurance reform legislatio...rnh/20080519/DNCLOGO ) ,, "Today, the Senate ... health insurance reform. By clearing this first p...unity to debate the health reform bill on the Sena...
Breaking Medicine News(10 mins):Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Surface bacteria maintain skin's healthy balance 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2
... Researchers may have discovered a better way to d...ressive treatment to prevent recurrence from those...udy is published in the May 1 issue of the New Eng...control the kinds and amount of proteins they make...
...vic organ prolapse a tear or weakness in a womans...ans to fall outside the body runs in families, a ...ith a family member who has had a hernia or prolap....D., director of the division of urogynecology at ...
...Allscripts, the leading,provider of clinical softw...hysicians use to improve healthcare, today announc...08., (Logo: http://www.newscom.com/cgi-bin/prnh/... last year,increasing by 11%. Revenue from softwar...
...-Year Revenue Increase of 80%; Gross Profit Improv...by 96%, ALISO VIEJO, Calif., April 30 Clarient, ...y and molecular testing services,resource for path...e from continuing operations was $15.9 million for...
...April 30 Hospira, Inc.,(NYSE: HSP ), a global sp...pany, today announced that Thomas E. Werner, senio...cer, will make a formal presentation at,the Bank o...2:40 p.m. Pacific time on,Wednesday, May 14, 2008....
...07 developed and began implementing a Strategic Pl...atient Safety Advisories to,improve patient safety...tions in hospitals and nursing homes began, HARRI...ivities more closely with its,educational and qual...
Other Medicine News:Health News:Molecular change may reveal risk of leukemia relapse 2Health News:Molecular change may reveal risk of leukemia relapse 3Health News:Family history places women at risk of pelvic organ prolapse, SLU research finds 2Health News:Allscripts Reports First Quarter 2008 Results 2Health News:Allscripts Reports First Quarter 2008 Results 3Health News:Allscripts Reports First Quarter 2008 Results 4Health News:Allscripts Reports First Quarter 2008 Results 5Health News:Allscripts Reports First Quarter 2008 Results 6Health News:Allscripts Reports First Quarter 2008 Results 7Health News:Allscripts Reports First Quarter 2008 Results 8Health News:Allscripts Reports First Quarter 2008 Results 9Health News:Allscripts Reports First Quarter 2008 Results 10Health News:Clarient Reports First Quarter 2008 2Health News:Clarient Reports First Quarter 2008 3Health News:Clarient Reports First Quarter 2008 4Health News:Clarient Reports First Quarter 2008 5Health News:Clarient Reports First Quarter 2008 6Health News:Clarient Reports First Quarter 2008 7Health News:Clarient Reports First Quarter 2008 8Health News:Patient Safety Authority Issues Annual Report for 2007 2Health News:Patient Safety Authority Issues Annual Report for 2007 3Health News:Patient Safety Authority Issues Annual Report for 2007 4Health News:Patient Safety Authority Issues Annual Report for 2007 5Health News:Patient Safety Authority Issues Annual Report for 2007 6Health News:Patient Safety Authority Issues Annual Report for 2007 7Health News:Patient Safety Authority Issues Annual Report for 2007 8Health News:Patient Safety Authority Issues Annual Report for 2007 9Health News:Patient Safety Authority Issues Annual Report for 2007 10Health News:Patient Safety Authority Issues Annual Report for 2007 11Health News:Patient Safety Authority Issues Annual Report for 2007 12Health News:Patient Safety Authority Issues Annual Report for 2007 13Health News:Patient Safety Authority Issues Annual Report for 2007 14Health News:Patient Safety Authority Issues Annual Report for 2007 15Health News:Patient Safety Authority Issues Annual Report for 2007 16Health News:Patient Safety Authority Issues Annual Report for 2007 17
(Date:11/20/2009).... 20 Cyberonics, Inc. (N...sident and Chief Executive Officer, and Greg Brown...st Annual Piper Jaffray Health Care Conference in ...M EST. The conference session and webcast will be.... Piper Jaffray will host a webcast of the presen...
(Date:11/20/2009)...J., Nov. 20 Soligenix, I...ompany), formerly known as DOR BioPharma, Inc., a ...that it has formed a consortium to develop thermos...pidly acting vaccines. Soligenix received a $9.4 m...y and Infectious Diseases (NIAID), a division of t...
(Date:11/19/2009)...o., Nov. 19 In a series ...ience, Heska Corporation (Nasdaq: HSKA ) ("Heska"...ts new and improved website. The upgraded site is...and programming to align the site with the company..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 1Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 2Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 3Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 4Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 5Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 6Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 7Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 8Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 9Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 10Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 11Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 12Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 13Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 14Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 15Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 16Sigma Aldrich 28Nasdaq 3ASIAL 29 Reports Q2 2009 Diluted EPS of 240 68 3B YTD Diluted EPS up 1 5 25 to 241 36 Full Year 2009 Guidance Reaffirmed 13165 17Narconon Trois Rivieres Cites Hillbilly Heroin as Canadian Drug Addiction Crisis 52510 1Narconon Trois Rivieres Cites Hillbilly Heroin as Canadian Drug Addiction Crisis 52510 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 1Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 2Patterson Companies Expands Deployment of MicroStrategy for Enhanced Reporting and Analytics 52508 3
...e SNS-595 to Next Stage of Phase 2 Trial Achieved,...OR RELEASE AT 3:30 P.M. EDT, TODAY/ -- Sunesis Pha...age biopharmaceutical company developing novel,ant...liminary results from,the first stage of the compa...oduct candidate, SNS-595, in platinum-resistant ov...
...WASHINGTON, Oct. 23 Boston,Scientific Corporation...,results from its CABERNET and BEACH carotid arter...the effectiveness of stenting with embolic,protect...ectomy (CEA), the,surgical treatment for carotid a...esults were presented by L. Nelson Hopkins, M.D., ...
Other Medicine Technology:Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 2Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 3Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 4Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference 5Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 2Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 3Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 4Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results 5
Brush Biopsy Sets
...oChoice® system is a set of 6 electric handpie... PowerPro®, or E9000® consoles. MicroChoic...lling, reaming, shaping and cutting of bone in a w...gery, Oral/Maxillofacial surgery, Facial Plastic S...
Unitized Electric Sagittal Saw, Throttleless
1000E Electric Motor Module, Throttleless
Medicine Products: